Education
About Us
Working with TipRanks
Follow Us
China Regenerative Medicine International Limited (HK:8158)
:8158
RESEARCH TOOLSreports
8158 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.09 - HK$1.27
Previous CloseN/A
Volume500.00
Average Volume (3M)243.19K
Market Cap
HK$197.76M
Enterprise ValueHK$170.94M
Total Cash (Recent Filing)HK$57.45M
Total Debt (Recent Filing)HK$53.69M
Price to Earnings (P/E)11.1
Beta0.27
Next Earnings
May 15, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.06
Shares Outstanding304,252,470
10 Day Avg. Volume263,927
30 Day Avg. Volume243,187
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)5.62
Price to Sales (P/S)0.00
P/FCF Ratio-926.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
8158 FAQ
What was China Regenerative Medicine International Limited’s price range in the past 12 months?
China Regenerative Medicine International Limited lowest stock price was HK$0.09 and its highest was HK$1.27 in the past 12 months.
What is China Regenerative Medicine International Limited’s market cap?
China Regenerative Medicine International Limited’s market cap is HK$197.76M.
When is China Regenerative Medicine International Limited’s upcoming earnings report date?
China Regenerative Medicine International Limited’s upcoming earnings report date is May 15, 2025 which is 60 days ago.
How were China Regenerative Medicine International Limited’s earnings last quarter?
China Regenerative Medicine International Limited released its earnings results on Mar 28, 2025. The company reported HK$0.003 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.003.
Is China Regenerative Medicine International Limited overvalued?
According to Wall Street analysts China Regenerative Medicine International Limited’s price is currently Overvalued.
Does China Regenerative Medicine International Limited pay dividends?
China Regenerative Medicine International Limited does not currently pay dividends.
What is China Regenerative Medicine International Limited’s EPS estimate?
China Regenerative Medicine International Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Regenerative Medicine International Limited have?
China Regenerative Medicine International Limited has 304,252,470 shares outstanding.
What happened to China Regenerative Medicine International Limited’s price movement after its last earnings report?
China Regenerative Medicine International Limited reported an EPS of HK$0.003 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 11.111%.
Which hedge fund is a major shareholder of China Regenerative Medicine International Limited?
Currently, no hedge funds are holding shares in HK:8158
China Regenerative Medicine International Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
306.25%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-48.74%
Trailing 12-Months
Company Description
China Regenerative Medicine International Limited
China Regenerative Medicine International Limited (8158) is a biotechnology company focused on the research, development, and commercialization of innovative regenerative medicine products and technologies. The company operates primarily in the field of tissue engineering, cell therapy, and stem cell research, offering solutions aimed at improving healthcare outcomes. Its core products include skin and organ regeneration products, as well as other advanced medical technologies designed to address unmet medical needs.
Technical Analysis
Transcenta Holding Limited
―
Sirnaomics Ltd.
―
Clover Biopharmaceuticals Ltd.
―
CANbridge Pharmaceuticals Inc.
―
Uni-Bio Science Group Ltd.
―